YEDITEPE UNIVERSITY VAKIF

Their core work

Yeditepe University is a private foundation university in Istanbul that has participated in EU-funded research across two distinct domains: social science (youth civic participation) and biomedical neuroscience (diagnostics of neurodegenerative diseases). Their most technically substantive contribution is in the AUTOIGG project, where they work on automated functional screening of immunoglobulins as diagnostic biomarkers for conditions such as ALS, using astrocyte-based cellular models, multi-electrode array (MEA) recordings, calcium signaling, and voltage-sensitive dye imaging. As a mid-sized Turkish private university, they serve as a specialist research partner rather than a project driver, contributing domain-specific laboratory expertise within international consortia.

What they specialise in

How they've shifted over time

In their first H2020 project (2015–2018), the university contributed to social science research on youth civic participation — a domain with no technical biomedical dimension. Their second and more recent project (2018–2023) marks a complete pivot toward biomedical neuroscience, specifically IgG-based diagnostics of ALS and related neurodegenerative diseases using astrocyte models and electrophysiological screening tools. The two projects share no thematic overlap, suggesting the university's EU engagement reflects different internal research groups rather than a single evolving research line. The most recent and technically detailed work points clearly toward neuroscience and diagnostics.

If AUTOIGG represents the active research group's direction, the university is moving toward biomarker-based diagnostics for neurodegenerative diseases — an area with strong future collaboration potential in clinical neuroscience and diagnostics technology consortia.

How they like to work

Yeditepe has never coordinated an H2020 project — both participations were as a consortium partner, which is consistent with the role of a smaller national university contributing specialized expertise rather than leading large EU initiatives. Across just two projects, they have accumulated 17 unique partners in 12 countries, indicating exposure to broad international consortia rather than a tight repeated network. This suggests they are open and accessible as a partner but have not yet built the administrative infrastructure or track record to lead major EU grants.

Despite only two projects, Yeditepe has worked with 17 distinct partners across 12 countries, reflecting participation in geographically diverse European consortia. No repeated partner relationships are visible at this scale, suggesting broad but shallow network connections rather than deep bilateral ties.

What sets them apart

Yeditepe is one of the few Turkish private universities with H2020 experience in both social sciences and biomedical neuroscience, giving it a cross-disciplinary footprint unusual for institutions of its size. Its AUTOIGG involvement places it in a technically specialized niche — IgG-based functional screening with MEA and calcium imaging tools — which is a relatively rare combination in Turkish academic EU participation. For consortium builders seeking a Turkish partner with neurological disease expertise or functional bioassay capabilities, Yeditepe's AUTOIGG track record is a concrete differentiator.

Highlights from their portfolio

• AUTOIGG
  The larger and more recent of the two projects, AUTOIGG is technically distinctive for combining automated immunoglobulin screening with astrocyte-based cellular assays and MEA electrophysiology for ALS diagnostics — a precise niche with real clinical translation potential.
• PARTISPACE
  Demonstrates that Yeditepe's EU engagement spans humanities and social science, not just biomedical research — useful context for consortium builders in the Society pillar looking for a Turkish academic partner.